Physician profile
Nancy Koshy
NPI 1255782488
$445.69
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $26.46 · 2021: $299 · 2022: $120.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $115.03 | 2020-2022 | |
| Novo Nordisk INC | $100.80 | 2021-2022 | |
| Lilly USA, LLC | $43.22 | 2021 | |
| Abbvie INC. | $33.88 | 2021-2022 | |
| Glaxosmithkline, LLC. | $29.96 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.74 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $14.99 | 2021 | |
| Lundbeck LLC | $14.32 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $13.95 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.63 | 2021 | |
| Hologic Sales and Service, LLC | $13.43 | 2021 | |
| Eisai INC. | $13.06 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.68 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Koshy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.